Medical Devices: Page 146


  • More Blue Cross plans now covering Senseonics' implantable glucose monitor

    The medtech recently snagged a new positive coverage decision from Health Care Services Corporation, the nation's fourth largest insurer, which operates Blue Cross Blue Shield plans covering 16 million members across five states.

    By Updated Oct. 15, 2019
  • Tool to bust coronary plaque with sonic waves wins FDA breakthrough nod

    Shockwave Medical, which went public in March, is enrolling patients in a pivotal trial to study the device in treating cardiovascular disease. Abiomed is among its backers.

    By Sept. 4, 2019
  • the FDA Headquarters Explore the Trendline
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Stryker spends up to $500M to boost spine unit with imaging, robotics tech

    The medtech said Monday it completed its buy of Mobius Imaging, which makes a mobile CT scanner, and Cardan Robotics, which develops radiology procedure technologies. 

    By Maria Rachal • Updated Oct. 21, 2019
  • Biotronik's Orsiro stent beats Abbott's Xience in head-to-head trial

    The trial linked the "ultrathin" Orsiro to a lower rate of target lesion revascularization than Abbott's incumbent device.

    By Sept. 4, 2019
  • FDA sets November ethylene oxide sterilization, duodenoscope safety advisory panel

    The dual-topic expert panel will be tasked with developing recommendations for FDA on two of the largest challenges currently facing the Center for Devices and Radiological Health.

    By David Lim • Sept. 3, 2019
  • Weight-loss surgery for Type 2 diabetes could cut major heart risks, study suggests

    Published in JAMA and funded by Medtronic, results from the retrospective study have yet to be confirmed by randomized clinical trials.

    By Maria Rachal • Sept. 3, 2019
  • Regulators put out call for experts to join device advisory committees

    FDA is seeking people to sit on 18 panels that review medical device data and manufacturing regulations.

    By Sept. 2, 2019
  • FDA urges providers, manufacturers to transition to duodenoscopes with disposable parts

    Boston Scientific told investors last year single-use duodenoscopes represent a market opportunity of more than $1 billion dollars.

    By David Lim • Aug. 30, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    Summer slowdown drags on for De Novos

    The FDA has not announced a De Novo clearance in 12 weeks. Two-thirds of the way through 2019, pacing suggests the overall number of novel device approvals won't match 2018's high.

    By Maria Rachal • Aug. 30, 2019
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    McKesson, Philips devices flagged by DHS for cyber vulnerabilities

    Certain cardiovascular IT systems and ultrasound devices could be exploited by hackers, the Department of Homeland Security wrote in separate notices.

    By Aug. 30, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    AdvaMed wins some, loses some in FDA guidance on managing uncertainty

    While the agency tweaked parts of the document in line with feedback from AdvaMed and other groups, it maintained its plan to hold advisory committee meetings on certain postmarket data and kept other contested proposals.

    By Aug. 30, 2019
  • Image attribution tooltip
    Kendall Davis
    Image attribution tooltip

    Medline, Vantage ethylene oxide emissions caused cancer, lawsuits claim

    Commercial sterilizer Sterigenics, which was forced to shut down a Willowbrook medical device sterilizing plant in February, is defending itself against at least 32 lawsuits in the same state court over similar claims.

    By David Lim • Aug. 29, 2019
  • Surmodics passes milestone in trial of Abbott-licensed paclitaxel-coated balloon

    Surmodics completed enrollment sooner than some analysts expected on a trial comparing its paclitaxel-coated balloon to Medtronic's IN.PACT Admiral.

    By Aug. 29, 2019
  • Elekta buys ProKnow to boost digital radiotherapy strategy

    The Swedish company says ProKnow's capabilities are of particular value to its large customers, potentially helping give it an edge over rivals such as Varian Medical Systems.

    By Aug. 29, 2019
  • Life Spine talks up global expansion weeks after DOJ hit

    The micro invasive spine tech maker says its products are now sold in 30 countries, including recent additions in South America.

    By Aug. 29, 2019
  • Medtronic's Ishrak set to retire after nearly decade as CEO

    The leadership shuffle paves the way for Restorative Therapies Group head Geoff Martha, who led Medtronic's nearly $43 billion takeover of Covidien in 2014, to take the helm in time for the medtech giant's next fiscal year.

    By Maria Rachal • Aug. 28, 2019
  • AtriCure gets expanded FDA label for atrial exclusion device

    AtriCure said it has strong growth from the AtriClip FLEX.V device and is confident growth rates for appendage management products will continue.

    By Aug. 28, 2019
  • FDA approves pediatric spine device via humanitarian pathway

    The device is a less invasive alternative to spinal fusion for adolescents with idiopathic scoliosis.

    By Aug. 28, 2019
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Titan Medical delays 510(k) submission until 2020 amid cash burn concerns

    The company plans to use the delay to spread out its spending while working to implement the robotic surgery system's sterile instrument interface components, software improvements and training tools.

    By David Lim • Aug. 27, 2019
  • Medicare contractors back use of Inspire's sleep apnea device

    Inspire Medical has now received draft decisions from four different Medicare contractors for the sleep apnea therapy, which could eliminate reimbursement "fatigue factors" the company says are limiting use of the product.

    By Updated Sept. 3, 2019
  • Breast implant makers vie for customers amid Allergan recall

    Even with greater awareness of cancer and chronic illness linked to breast implants, consumer interest does not appear to have waned.

    By Maria Rachal • Aug. 26, 2019
  • Image attribution tooltip
    Wikipedia user Coolcaesar / edited by Industry Dive
    Image attribution tooltip

    Dexcom beats WaveForm's patent suit over CGM sensors

    A U.S. District Court judge's decision ends the ongoing dispute between San Diego-based continuous glucose monitor maker Dexcom and WaveForm Technologies, a subsidiary of blood glucose meter manufacturer AgaMatrix.

    By Dana Elfin • Aug. 26, 2019
  • Image attribution tooltip
    Brian Tucker
    Image attribution tooltip

    Big data, cybersecurity among top FDA device center priorities

    Reprocessing of devices and biocompatibility are also addressed in a report intended to incorporate new tech into regulatory decisions.

    By David Lim • Aug. 23, 2019
  • Heart attack device earns FDA's breakthrough nod

    Miracor Medical began a 144-patient clinical trial in July to examine effectiveness of its device. Earlier studies ran into hurdles.

    By Aug. 23, 2019
  • Medicare draft decisions may boost Natera, Myriad tests

    Cowen analysts called proposed local coverage for Natera's colorectal cancer test as "materially broader and quicker than expected," while documents on pharmacogenomic tests gave a mixed outlook for Myriad Genetics' products.

    By Aug. 23, 2019